What is Telix Pharmaceuticals Limited's Shariah compliance score?

Telix Pharmaceuticals Limited (TLX) has a Shariah compliance score of 70/100 (Grade: B+, Good) based on AAOIFI screening standards. Scores above 70 typically indicate strong compliance. The score factors in business activity screening and financial ratio analysis including debt levels, interest-bearing deposits, and prohibited income percentages. View the full breakdown at HalalScreener.app.

Does Telix Pharmaceuticals Limited pass AAOIFI screening?

Telix Pharmaceuticals Limited (TLX) passes AAOIFI Shariah screening. AAOIFI requires: (1) no primary involvement in prohibited activities like alcohol, gambling, or conventional banking, (2) debt-to-market-cap below 30% (TLX: 24.5%), (3) interest-bearing deposits below 30% (TLX: 6.6%), and (4) prohibited income below 5% (TLX: 0.7%). HalalScreener provides free AAOIFI screening for 10,000+ stocks at halalscreener.app.

How much purification is needed for Telix Pharmaceuticals Limited stock?

Telix Pharmaceuticals Limited (TLX) has a non-permissible income ratio of 0.72%. Muslim investors should purify this percentage of any dividends received and capital gains realized from TLX shares by donating it to charity. HalalScreener's purification calculator at halalscreener.app/en/purification automates this calculation using the latest financial data.

Where can I screen Telix Pharmaceuticals Limited for Shariah compliance for free?

HalalScreener (halalscreener.app) offers free Shariah compliance screening for Telix Pharmaceuticals Limited (TLX) and 10,000+ other US-listed stocks, ETFs, and 100+ cryptocurrencies. The screening uses AAOIFI Standard No. 21 and shows all financial ratios transparently. No credit card or signup required for basic screening. HalalScreener also includes an AI Islamic Scholar for follow-up questions about TLX's compliance across different madhabs (Hanafi, Shafi'i, Maliki, Hanbali, Ja'fari).

Is Telix Pharmaceuticals Limited (TLX) halal? Halal. Based on AAOIFI screening, Telix Pharmaceuticals Limited passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 70/100 (Grade: B+).

TLX: Is Telix Pharmaceuticals Limited Halal?

Halal

Telix Pharmaceuticals Limited

NASDAQHealthcareAU

$9.45

+0.11%

AvoidBorderlineClean

Purify ~0.7% of income

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited (TLX) is a commercial-stage biopharmaceutical entity specializing in the creation and distribution of advanced radiopharmaceuticals. Its core mission is to develop both diagnostic agents and therapeutic treatments for cancer and rare diseases across key international markets, including Australia, Belgium, Japan, Switzerland, and the United States. Among its currently available products, Telix offers Illuccix, designed for the management of prostate cancer, and TLX66-CDx, which serves as an imaging agent for osteomyelitis. The company also maintains a robust pipeline of investigational candidates aimed at various conditions: Prostate Cancer: TLX591, a radio antibody-drug conjugate, and TLX592, a candidate for targeted alpha therapy. Renal (Kidney) Cancer: TLX250-CDx, intended for both diagnosis and treatment, and TLX250, specifically for clear cell renal cell carcinoma. Brain Cancer: This includes TLX101-CDx and TLX101, which targets glioblastoma. Bone Marrow Conditioning: TLX66-CDx and TLX66 are being explored. Soft Tissue Sarcoma: TLX300-CDx and TLX300 are under development for diagnosis and treatment. Founded in 2015, Telix Pharmaceuticals Limited is based in North Melbourne, Australia.

Sector: Healthcare · Industry: Biotechnology

Shariah Compliance Status

AAOIFI Standard 21Updated Jun 12, 2026

B+

Good

Good compliance with minor concerns

70Score

Business Activity Screen

Passed

Checks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)

Financial Ratio Screen

Passed

Financial ratios must be below AAOIFI thresholds

Debt / Market Cap24.5% / 30.0%

Compliance History

Halalnow
since Jun 2026
Doubtful
until the change above
Halal
until the change above

Tracked since May 2026. Updates automatically on each re-screen.

Screened: Jun 12, 2026Fiscal: FY 2025Source: FMP

Purify Your TLX Dividends

0.7% non-compliant income

TLX has 0.7% prohibited income. Calculate exactly how much of your dividends to donate.

Financial Overview

Market Cap

3.2B

Price

$9.45

Sector

Healthcare

Industry

Biotechnology

More Healthcare Stocks

JNJ

Johnson & Johnson

UNH

UnitedHealth Group Incorporated

B+

ABBV

AbbVie Inc.

PFE

Pfizer Inc.

LLY

Eli Lilly and Company

A+

MRK

Merck & Co., Inc.

B+

Free · No credit card required

Track TLX and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

Get Started Free Browse Screener

10,000+ assets AAOIFI standards Free watchlist

Frequently Asked Questions

Is Telix Pharmaceuticals Limited (TLX) halal to invest in?

Based on AAOIFI Standard 21 screening, Telix Pharmaceuticals Limited (TLX) is rated Halal with a compliance grade of B+ (Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).

Why did Telix Pharmaceuticals Limited get a B+ compliance rating?

Telix Pharmaceuticals Limited (TLX) received a grade of B+ (Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 24.5% (limit 30%); interest-bearing deposits of 6.6% (limit 30%); prohibited income of 0.72% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.

What could change Telix Pharmaceuticals Limited's Shariah verdict?

Telix Pharmaceuticals Limited's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.

How often is Telix Pharmaceuticals Limited re-screened for Shariah compliance?

Telix Pharmaceuticals Limited (TLX) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jun 12, 2026.

Screened according to AAOIFI Standard No. 21 · For informational purposes only. Consult a qualified Islamic finance advisor before investing.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.